While it has been demonstrated that Til can inhibit neuroinflammation in activated BV2 microglia through the TRAF-6/NF-κB/p38 pathway [22], its broader impact on the complex pathogenesis of PD, encompassing dopaminergic dysfunction and disease progression, requires deeper investigation. Here, NFKB1 is linked to Parkinson disease.